At present, the blood-brain barrier (BBB) poses a challenge for treating a wide range of central nervous system disorders; reliable BBB models are still needed to understand and manipulate the transfer of molecules into the brain, thereby improving the efficiency of treatments. In this study, hollow, cell-laden microfibers are fabricated and investigated as a starting point for generating BBB models. The genetic effects of the manufacturing process are analyzed to understand the implications of encapsulating cells in this manner. These fibers are created using different manufacturing parameters to understand the effects on wall thickness and overall diameter. Then, dopaminergic rat cells are encapsulated into hollow fibers, which maintained at least 60% live cells throughout the three-day observation period. Lastly, genetic changes TH and TUBB-3 are investigated to elucidate the effects on cell health and behavior; while the TH levels in encapsulated cells were similar to control cells, showing similar levels of tyrosine hydroxylase synthesis, TUBB-3 was downregulated, indicating lower amounts of cellular neurogenesis.As the national and international population continues to grow older, age-related neuropathologies continue to be a tragic and expensive bane of modern times, with Alzheimer's alone projected to cost 1.1 trillion dollars per year by 2050, 1 while general neurological disorders account for 12% of the total global deaths. 2 Similarly, there is a dire need to treat other neurological disorders, such as mental illnesses, cancers, or traumatic brain injuries (TBIs), which are widespread and are detrimental to a wide age range. [3][4] In spite of this urgency, a currently insurmountable challenge has blocked efforts thus far; while it is crucial to protect the integrity of the central nervous system (CNS), the blood-brain barrier (BBB) blocks more than 98% of small molecules and all large molecules, thwarting almost all efforts to provide therapeutics to the brain. 5 Creating physiologically relevant BBB models is a crucial step to providing care for millions of patients across the globe, as it will allow for the rapid and reliable creation of effective neuropharmacological molecules.